Ontario's leading advocate for the life sciences sector
Dawn joined TranQool because she felt that people need a platform where they can access counselling and services right at their fingertips.
TranQool enables you to talk with a real therapist in the comfort of your own home. You sign up. are matched with a therapist, have one-on-one video calls and build on your progress with assignments.
For the interview click here
OBIO was invited to McMaster University by Susan Searls Giroux, Assistant Vice-President of McMaster University for a day filled with science, bus and partnerships.
The day started with a tour of the Biointerfaces Institute with the impressive John Brennan, Director of the Biointerfaces Institute. The discussion during the tour focused on diagnostics, cell therapies and biointerfaces and what the current and future needs will be for companies.
Pathcore Heading South to 43North!
OBIO Pre-CAAP Company Pathcore has made it to the 43North semi-finals in Buffalo this fall!
Every year 43North awards $5 MILLION in capital, including a grand prize of $1 Million, to truly remarkable startups from around the world.
Learn more here
Aug 18, 2016 - Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a first-of-its-kind topical treatment developed to significantly reduce surgical scarring.
For the full press release click here
Jessica Ching, Co-Founder of Eve Medical won the Alumni Achievement Award. Eve Medical was selected for the 2014 "Next 36" class, and was honored for its achievements since graduating the intensive program.
For the full press release, click here
AUG 15, 2016 – VANCOUVER - The Top 10 finishers in the 2016 INTERFACE Health Challenge X have been selected. INTERFACE Health Challenge X is the world’s only annual competition to discover the world’s best digital health innovators.
This year's challenge started on March 1st at HiMSS 2016 in Las Vegas with this Call to discover the world's best digital health innovators.
OBIO CAAP Companies Medella Heath & Shift Health were among the finalists, as well as Pre-CAAP comapny NERv Technology.
For the full article, click here
Former OBIO CAAP company MyndTec's MyndMove™ was highlighted on CTV News regarding brain-controlled robots helping paralyzed patients move again and the newly release study by Duke University, published in Nature.
MyndMove is already in use for upper body rehabilitation in parts of Canada.
"We have seen dramatic improvement in stroke and spinal cord patients,” said brainchild of MyndMove, Dr. Milos R. Popovic, the Toronto Rehab Institute Chair in Spinal Cord Injury Research and Professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.
For the video, click here
For the full text of the Duke study, click here
Congratulations to OBIO Pre-CAAP company iMerciv on being selected to compete at this years CNE Innovation Garage from August 19th - 21st (Enercare Centre at the CNE). 25 innovators from across the province will come together to compete in 5 categories for $25,000 Grand Prize!
The iMerciv BuzzClip is an assistive device that caters to the orientation & mobility needs of blind, deaf-blind and visually impaired communities around the globe.
The Bio-tech Competition takes place: Friday August 19 @ 3pm. Remember to tweet and use the hashtag #cdntech
Learn more about the CNE Innovation Garage here
Stay Away from Me...I Am Sick
OBIO Pre-CAAP Company iamsick.ca knows that the last thing you want to do when you are sick is look for a family doctor, a walk-in-clinic or a nearby pharmacy. The new app informs patients on what clinics are nearby (in your actual area) and pharmacies and to find out what clinics are accepting new patients (great when you move to a new area!) and book appointments online.
For the full article click here
Komodo's TECLA technology is making the wildly popular Pokemon GO game more accessible to wheelchair users and others with limited range of motion.
For the full story and video, click here
Former OBIO CAAP company Eve Medical was highlighted on CBC News. The EVE Kit is gearing up to be ready for purchase online this fall!
"Canadian women may be able to self-administer tests for sexually transmitted infections from the comfort of their own homes, for less than $100."
CEO Jessica Ching says, the hope is to make "it more convenient for women to test for HPV which could guard against cervical cancer."
Follow their progress and updates on Twitter @evemedical
For the CBC feature click here
Aug 8, 2016 - 4 OBIO Pre-CAAP companies have been selected as winners of the Ontario Brain Institute (OBI) 2016 ONtrepreneurs Program!
Congratulations to Winterlight Labs, SensOR Medical Laboratory, TopSpin360 & iMerciv!
The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program helps "Ontario neurotech entrepreneurs take their ideas from the lab to the marketplace."
This year's winners participated in a pitching competition to a panel of "expert judges from organizations including Yocto Law, Biomedical Zone, Emmetros, AGE-WELL, Ironstone Product Development Inc. and OBI."
$300,000 ($50,000 each) has been awarded to the winners to assist with commercializing their neurotechnologies.
For the full press release, click here
CellAegis autoRIC® Device, which reduces heart damage in ischemic heart disease, is now being clinically implemented in Peel-Halton Region, West of Toronto. The autoRIC® Device is being used to treat all patients having heart attacks, in addition to standard treatment. The FIRST study (Field Implementation of autoRIC Device in STEMI (ST-segment Myocardial Infarction)) is the first clinical implementation of our device across an entire region, and is expected to be the first of many such clinical implementations, as the benefit of Remote Ischemic Conditioning therapy becomes more widely utilized.
For the full press release click here
July 21, 2016 KITCHENER — A startup developing a low-cost, high-resolution digital X-ray imager to detect lung disease in developing nations has received a $1-million boost.
The new money from federally funded Grand Challenges Canada will help KA Imaging build a prototype and test it in the field in Zambia by the end of the year.
For the full article click here
For the Grand Challenges press release, click here
OBIO Innovation Agenda Leader
On July 21st, Gail Garland, CEO of OBIO attended the Federal Government's Global Science Excellence Roundtable, part of the Inclusive Innovation Agenda Strategy held in Ottawa.
The ideas generated during the session will be consolidated and presented to Minister Navdeep Bains for consideration as part of the Inclusive Innovation Agenda report.
For the full report, click here
For the Innovation Submission page, click here
July 19, 2016 TORONTO – iTP Biomedica Corp., a developer of proprietary whole transcriptome-based cancer diagnostics, today announced the launch of BladderPredict, a groundbreaking next-generation sequencing-based test that will for the first time assist uro-pathologists in assigning disease grade in early stage bladder cancer, and urologists and uro-oncologists in managing the disease.
For the full press release, click here
July 7, 2016 - TranQool. an online platform that matches users with registered Cognitive Behavioural Therapy (CBT) therapists and lets them connect via secure video calls, was featured in Canadian Healthcare Technology magazine.
July 6, 2016 - CAAP Company Eve Medical and their CEO, Jessica Ching, are featured in the August issue of Chatelaine.
